MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
$7.79-$0.58 (-6.95%) Today
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 2 | 50,000 | $254K |
| Tax withholding / forfeiture | 5 | 480,550 | |
| Bona-fide gift | 2 | 92,586 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
38 Form 4 filings on record, the earliest from Oct 16, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Rebecca Buzzeo - Officer | Tax withholding / forfeiture | Class A Common Stock | 4,363 | $4.42 | $19K | |
| John A. Deford - Director | Open-market purchase | Class A Common Stock | 17,500 | $5.75 | $101K | |
| Carl Hull - Officer | Open-market purchase | Class A Common Stock | 175,000 | $5.64 | $987K | |
| Christine Dolan - Officer | Grant or award | Class A Common Stock | 1,848 | $5.70 | $11K | |
| Andrew Burch - Officer | Grant or award | Class A Common Stock | 1,841 | $5.70 | $10K | |
| Kurt Oreshack - Officer | Grant or award | Class A Common Stock | 366 | $5.70 | $2K | |
| Kevin Herde - Officer | Grant or award | Class A Common Stock | 1,906 | $5.70 | $11K | |
| William E. Martin III - Officer | Tax withholding / forfeiture | Class A Common Stock | 50,843 | $8.29 | $421K |
This is as far as the anonymous view goes. Create a free account for all 38 MRVI filings on record.
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR |
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) had 7 insider filings in the last 90 days, with the most recent on 2026-08-11. The full record for MRVI runs to 38 Form 4 filings, the earliest from 2024-10-16. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of MRVI were filed in the last 90 days. 5 purchases are on record for this company.
2 insider sales of MRVI were filed in the last 90 days, totaling $254K.
This page tracks MRVI Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add MRVI to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
